iCHIP® Platform

ImmunArray’s iCHIP® technology mines the information stored in the immune system repertoires in order to shed light on an individual’s specific immune profile.

Learn More

iCHIP intensity


SLE-key® is a molecular diagnostic test developed by ImmunArray to support a physician’s ability to rule-out a diagnosis of Systemic Lupus Erythematosus (SLE).

Learn More


TBI Program

Immunarray® is developing a series of assays and multiplex tests to assist in the diagnosis and prognosis of Brain Injury, in both acute (TBI) and chronic phases.

Learn More

See us at

See Us At

NNS 2016 (National Neurotrauma Society)

June 26 – June 29, 2016, Lexington, Kentucky 

Title: A Panel of 3 Serum Biomarkers Accurately Identifies Brain Injured Patients.

Read More

Recent News & Events

Experienced Diagnostic Executive Named to ImmunArray Board

Dick Aderman brings 35 years of diagnostics and healthcare
experience to company board

Rehovot, Israel and Richmond, Va., May 2, 2016 – Dick Aderman, the president and CEO of HYCOR Biomedical whose career in the business side of diagnostics and healthcare spans almost four decades, has been named to the board of directors of ImmunArray, a private molecular diagnostics company co-headquartered in Rehovot, Israel and Richmond, Virginia.

Read More

Talk to Us


We are a clinically driven company guided by leadership physician input at each stage of our development. We welcome questions and open discussions, and look forward to continuing to work with our collaborators and partners around the globe.

Read More